ATOPIC
Clinical trials for ATOPIC explained in plain language.
Never miss a new study
Get alerted when new ATOPIC trials appear
Sign up with your email to follow new studies for ATOPIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for severe skin rash and itch
Disease control CompletedThis study tested a new drug called camoteskimab for adults with moderate to severe eczema (atopic dermatitis). For the first 16 weeks, some participants received the drug and others received a placebo, then everyone received the drug. The main goal was to see if the drug safely …
Matched conditions: ATOPIC
Phase: PHASE2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New eczema drug tested for Kids' itching
Symptom relief CompletedThis study tested if a medication called TAU-284 works as well as an existing drug (ketotifen) to reduce itching in children with atopic dermatitis, also known as eczema. It involved 303 children aged 7 to 15. The main goal was to see if the new treatment was not worse than the s…
Matched conditions: ATOPIC
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC